{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:03:54Z","timestamp":1788206634231,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.critrevonc.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T02:46:42Z","timestamp":1363142802000},"page":"323-332","source":"Crossref","is-referenced-by-count":60,"title":["Acquired C1-inhibitor deficiency and lymphoproliferative disorders: A tight relationship"],"prefix":"10.1016","volume":"87","author":[{"given":"Roberto","family":"Castelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2013.02.004_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","article-title":"Acquired C1-inhibitor deficiency in lymphosarcoma","volume":"1","author":"Caldwell","year":"1972","journal-title":"Clinical Immunology and Immunopathology"},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2013.02.004_bib0010","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angio-oedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0020","first-page":"211","article-title":"C1 inhibitor deficiency: hereditary and acquired forms","volume":"11","author":"Kaplan","year":"2001","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0025","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI114555","article-title":"Plasma levels of C1-inhibitor complexes and cleaved C1-inhibitor in patients with hereditary angioneurotic edema","volume":"85","author":"Cugno","year":"1990","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0030","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM198305053081802","article-title":"Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema","volume":"308","author":"Schapira","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0035","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0040","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0055","first-page":"129","article-title":"Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin","volume":"120","author":"Kleniewski","year":"1992","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0060","first-page":"38","article-title":"Generation of plasmin during acute attacks of hereditary angioedema","volume":"121","author":"Cugno","year":"1993","journal-title":"Journal of Laboratory and Clinical Medicine"},{"issue":"6090","key":"10.1016\/j.critrevonc.2013.02.004_bib0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/323722a0","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"323","author":"Jackson","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1-inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0075","first-page":"523","article-title":"Acquired C1-inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-866.x","article-title":"Relevance of lymphoproliferative disorders and of anti-C1-inhibitor autoantibodies in acquired angio-oedema","volume":"106","author":"Cicardi","year":"1996","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3324\/haematol.10769","article-title":"Lymphoproliferative disease and acquired C1-inhibitor deficiency","volume":"92","author":"Castelli","year":"2007","journal-title":"Haematologica"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2013.02.004_bib0095","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.clml.2011.02.005","article-title":"Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia","volume":"11","author":"Jung","year":"2011","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0100","first-page":"126","article-title":"Acquired angioedema associated with hereditary angioedema due to C1-inhibitor deficiency","volume":"18","author":"Guilarte","year":"2008","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0105","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI113934","article-title":"Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema","volume":"83","author":"Jackson","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1172\/JCI112610","article-title":"Demonstration of modified inactive first component of complement C1-inhibitor in the plasmas of C1-inhibitor-deficient patients","volume":"78","author":"Zuraw","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM198502283120902","article-title":"Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins","volume":"312","author":"Geha","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000018252","article-title":"Acquired angioedema with C1-inhibitor deficiency: is the distinction between type I and type II still relevant?","volume":"199","author":"D\u2019Incan","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0125","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.156.5.2009","article-title":"Epitope mapping of C1-inhibitor autoantibodies from patients with acquired C1-inhibitor deficiency","volume":"156","author":"He","year":"1996","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2008.05.003","article-title":"Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoprolipheration","volume":"8","author":"Cugno","year":"2008","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1 inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0140","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH10-01-0073","article-title":"C1-inhibitor, a multi-functional serine protease inhibitor","volume":"104","author":"Davis","year":"2010","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0145","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1016\/S0021-9258(18)69022-2","article-title":"Functional and structural similarities between protease nexin I and C1-inhibitor","volume":"263","author":"Van Nostrand","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00001721-200106000-00005","article-title":"In vitro interaction of C1-inhibitor with thrombin","volume":"4","author":"Cugno","year":"2001","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/MBC.0b013e3283494ba7","article-title":"Interaction of C1-inhibitor with thrombin on the endothelial surface","volume":"7","author":"Caccia","year":"2011","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1398-9995.2008.01859.x","article-title":"Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency","volume":"64","author":"Cugno","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0165","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2011.04541.x","article-title":"Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency","volume":"167","author":"van Geffen","year":"2012","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jcp.1041280115","article-title":"Thrombin induced increase in albumin permeability across the endothelium","volume":"128","author":"Garcia","year":"1986","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0175","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00001721-199510000-00001","article-title":"Vascular endothelial cell activation and permeability responses to thrombin","volume":"6","author":"Garcia","year":"1995","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0180","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1160\/TH10-11-0711","article-title":"Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects","volume":"106","author":"Siller-Matula","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired C1-inhibitor deficiency: presentation, diagnosis, course and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunology and Allergy Clinics of North America"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0195","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/039463201102400433","article-title":"Acquired angioedema with C1-inhibitor deficiency associated with anticardiolipin antibodies","volume":"24","author":"Di Leo","year":"2011","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1-inhibitor deficiency","volume":"101","author":"Bork","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2013.02.004_bib0205","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2500\/aap.2011.32.3472","article-title":"Update on laboratory tests for the diagnosis and differentiation of hereditary angioedema and acquired angioedema","volume":"32","author":"Frazer-Abel","year":"2011","journal-title":"Allergy and Asthma Proceedings"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0210","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.149.5.1213","article-title":"Acquired angioedema and anti-C1-inhibitor autoantibody","volume":"149","author":"Spath","year":"1989","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(93)90257-P","article-title":"Autoimmune C1-inhibitor deficiency: report of eight patients","volume":"95","author":"Cicardi","year":"1993","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0220","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0091-6749(86)80111-7","article-title":"The metabolism of C1-inhibitor and C1q in patients with acquired C1-inhibitor deficiency","volume":"77","author":"Melamed","year":"1986","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJM198801143180217","article-title":"Autoantibody-mediated acquired deficiency of C1-inhibitor","volume":"318","author":"Jackson","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0230","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198705283162202","article-title":"Autoantibody-mediated acquired deficiency of C1-inhibitor","volume":"316","author":"Alsenz","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/08923973.2012.726627","article-title":"Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic","volume":"35","author":"Castelli","year":"2013","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0240","first-page":"333","article-title":"Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Treatment, follow-up, and special situations","volume":"21","author":"Caballero","year":"2011","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0245","first-page":"422","article-title":"Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations","volume":"21","author":"Caballero","year":"2011","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2013.02.004_bib0250","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1710-1492-7-S1-S9","article-title":"Urticaria and angioedema","volume":"7","author":"Kanani","year":"2011","journal-title":"Allergy, Asthma and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2007.10.048","article-title":"Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P","volume":"121","author":"Drouet","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0260","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-6749(89)90082-1","article-title":"Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency","volume":"83","author":"Bork","year":"1989","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0265","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1398-9995.2012.02853.x","article-title":"Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study","volume":"67","author":"Zanichelli","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0270","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.tripleo.2006.11.015","article-title":"Acquired angioedema in non-Hodgkin's lymphoma","volume":"103","author":"Healy","year":"2007","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0275","first-page":"143","article-title":"Anaplastic large cell lymphoma and acquired angioedema: a novel association?","volume":"17","author":"Rossi","year":"2002","journal-title":"Annali Italiani di Medicina Interna"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2249.2011.04460.x","article-title":"Translational mini-review series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjogren's syndrome: clinical implications and effects of B cell-targeted therapies","volume":"167","author":"Vossenkper","year":"2012","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amjmed.2011.09.010","article-title":"B-cell-depleting therapy in systemic lupus erythematosus","volume":"125","author":"Ramos-Casals","year":"2012","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/annrheumdis-2011-200198","article-title":"Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis","volume":"7","author":"Boumans","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0295","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2133.2011.10411.x","article-title":"Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients","volume":"165","author":"Kim","year":"2011","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2011.10663.x","article-title":"Low-dose rituximab is effective in pemphigus","volume":"166","author":"Horv\u00e1th","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0305","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.seminhematol.2010.01.008","article-title":"German High-Grade Non-Hodgkin Lymphoma Study Group. Rituximab in high-grade lymphoma","volume":"47","author":"Zwick","year":"2010","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.seminhematol.2010.01.003","article-title":"Rituximab in indolent lymphomas","volume":"47","author":"Sousou","year":"2010","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0315","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0320","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0325","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMct1114348","article-title":"Anti-CD20 antibody therapy for B-cell lymphomas","volume":"366","author":"Maloney","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0330","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10875-012-9691-2","article-title":"Acquired C1-inhibitor deficiency: 7 patients treated with rituximab","volume":"32","author":"Branellec","year":"2012","journal-title":"Journal of Clinical Immunology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0335","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1200\/JCO.2011.38.9957","article-title":"Acquired angioedema and marginal zone lymphoma","volume":"30","author":"Lam","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0340","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.09.018","article-title":"Rituximab-induced elimination of acquired angioedema due to C1-inhibitoribitor deficiency","volume":"119","author":"Levi","year":"2006","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0345","first-page":"ELT13","article-title":"Acquired angioedema: a new target for rituximab?","volume":"89","author":"Ziakas","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0350","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0961203307087405","article-title":"Successful use of rituximab in acquired C1-inhibitor deficiency secondary to Sjogren's syndrome","volume":"17","author":"S\u00e1nchez-Cano","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0355","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2340\/00015555-1157","article-title":"Acquired angioedema responding to rituximab","volume":"91","author":"Hassan","year":"2011","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0365","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrrheum.2011.62","article-title":"Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma","volume":"7","author":"Dias","year":"2011","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.critrevonc.2013.02.004_bib0370","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fremeaux-Bacchi","year":"2002","journal-title":"American Journal of Medicine"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T06:21:43Z","timestamp":1688106103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842813000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1040842813000474"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2013.02.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}